Legato Capital Management LLC Sells 7,313 Shares of The Ensign Group, Inc. $ENSG

Legato Capital Management LLC lessened its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 52.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,730 shares of the company’s stock after selling 7,313 shares during the period. Legato Capital Management LLC’s holdings in The Ensign Group were worth $1,172,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Private Trust Co. NA boosted its holdings in shares of The Ensign Group by 156.5% during the 4th quarter. Private Trust Co. NA now owns 159 shares of the company’s stock valued at $28,000 after buying an additional 97 shares in the last quarter. Harbor Investment Advisory LLC boosted its holdings in shares of The Ensign Group by 125.6% during the 4th quarter. Harbor Investment Advisory LLC now owns 194 shares of the company’s stock valued at $34,000 after buying an additional 108 shares in the last quarter. Root Financial Partners LLC bought a new stake in shares of The Ensign Group during the 3rd quarter valued at $35,000. Larson Financial Group LLC boosted its holdings in shares of The Ensign Group by 76.9% during the 3rd quarter. Larson Financial Group LLC now owns 207 shares of the company’s stock valued at $36,000 after buying an additional 90 shares in the last quarter. Finally, Caitlin John LLC bought a new stake in shares of The Ensign Group during the 3rd quarter valued at $39,000. Institutional investors own 96.12% of the company’s stock.

Insider Transactions at The Ensign Group

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $199.97, for a total value of $78,388.24. Following the completion of the transaction, the director owned 9,295 shares of the company’s stock, valued at approximately $1,858,721.15. The trade was a 4.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $196.65, for a total value of $137,655.00. Following the completion of the transaction, the director directly owned 22,152 shares of the company’s stock, valued at approximately $4,356,190.80. This trade represents a 3.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,592 shares of company stock worth $512,364. 4.00% of the stock is currently owned by company insiders.

The Ensign Group Stock Performance

Shares of The Ensign Group stock opened at $171.94 on Monday. The stock has a market cap of $10.05 billion, a price-to-earnings ratio of 28.00, a PEG ratio of 1.69 and a beta of 0.73. The firm’s 50-day moving average is $192.17 and its 200 day moving average is $188.64. The Ensign Group, Inc. has a 1 year low of $134.79 and a 1 year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.56 and a quick ratio of 1.56.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.79 by $0.06. The company had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.40 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The Ensign Group’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.52 EPS. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Sell-side analysts anticipate that The Ensign Group, Inc. will post 6.79 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, April 30th. Investors of record on Tuesday, March 31st were paid a $0.065 dividend. The ex-dividend date was Tuesday, March 31st. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The Ensign Group’s payout ratio is presently 4.23%.

Analysts Set New Price Targets

A number of brokerages have recently commented on ENSG. UBS Group set a $230.00 target price on shares of The Ensign Group and gave the company a “buy” rating in a report on Friday, February 6th. Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a report on Tuesday, April 21st. Royal Bank Of Canada reiterated an “outperform” rating and issued a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Truist Financial set a $215.00 price target on shares of The Ensign Group and gave the stock a “hold” rating in a research note on Friday, February 6th. Finally, Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, The Ensign Group has a consensus rating of “Moderate Buy” and a consensus target price of $216.75.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.